|
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
An EC 3.1.* (ester hydrolase) inhibitor that interferes with the action of a phosphoric diester hydrolase (EC 3.1.4.*).
(via dyphylline )
|
|
|
bronchodilator agent
An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
(via dyphylline )
vasodilator agent
A drug used to cause dilation of the blood vessels.
(via dyphylline )
muscle relaxant
A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.
(via dyphylline )
|
|
|
7-[(2S)-2,3-dihydroxypropyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
(S)-diprophylline
|
ChEBI
|
|
1,3-dimethyl-7-[(2S)-2,3-dihydroxypropyl]xanthine
|
ChEBI
|
|
7-[(2S)-2,3-dihydroxypropyl]-1,3-dimethylxanthine
|
ChEBI
|
|
7-[(2S)-2,3-dihydroxypropyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione
|
ChEBI
|
|
7-[(2S)-2,3-dihydroxypropyl]theophylline
|
ChEBI
|
|
[(2S)-1,2-dihydroxy-3-propyl]thiophyllin
|
ChEBI
|
|
1222226
|
Beilstein Registry Number
|
Beilstein
|
|
1222226
|
Reaxys Registry Number
|
Reaxys
|
12-